Sharp Shalini
Insider CIK 1377202 · AGEN CFO, Director · ARRY Director · DTIL Director · STRO Director · RARE EVP, Finance · MRTX Director · BGNE Director · NUVB Director · OGN Director · SEPN Director · IAM Director · NBIX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IAM Iambic Therapeutics, Inc. | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2026-06-26 | 2026-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OGN Organon & Co. | A Award deriv | 2026-06-12 | 2026-06-15 | 17,857 | $13.44 | $240.0K | 81,496 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award | 2026-06-11 | 2026-06-15 | 18,980 | — | $0 | 38,116 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-05-27 | 2026-05-29 | 2,567 | — | $0 | 2,567 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-21 | 2026-05-21 | 1,659 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-21 | 2026-05-21 | 1,659 | — | $0 | 4,088 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2025-06-17 | 2025-06-20 | 16,623 | — | $0 | 16,623 | SEC↗ |
| OGN Organon & Co. | A Award deriv | 2025-06-13 | 2025-06-16 | 23,904 | $10.04 | $240.0K | 63,054 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-05-22 | 2025-05-22 | 1,435 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-05-22 | 2025-05-22 | 1,435 | — | $0 | 2,429 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-05-21 | 2025-05-22 | 1,659 | — | $0 | 1,659 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-05-21 | 2025-05-22 | 3,305 | — | $0 | 3,305 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2025-05-21 | 2025-05-22 | 22,750 | — | $0 | 22,750 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2025-05-21 | 2025-05-22 | 10,985 | — | $0 | 19,136 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2024-09-30 | 2024-10-02 | 17,238 | — | $0 | 17,238 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2024-09-30 | 2024-10-02 | 8,151 | — | $0 | 8,151 | SEC↗ |
| OGN Organon & Co. | A Award deriv | 2024-06-07 | 2024-06-11 | 9,639 | $20.75 | $200.0K | 36,784 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-05-22 | 2024-05-23 | 2,982 | — | $0 | 2,982 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-05-22 | 2024-05-23 | 1,435 | — | $0 | 1,435 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-17 | 2024-05-21 | 2,100 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-17 | 2024-05-21 | 2,100 | — | $0 | 2,100 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-17 | 2024-05-21 | 1,106 | $141.90 | $156.9K | 994 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 7,520 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 4,162 | — | $0 | 12,060 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 5,252 | — | $0 | 6,808 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,808 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 6,808 | $58.75 | $400.0K | 16,222 | SEC↗ |
| OGN Organon & Co. | A Award deriv | 2023-06-09 | 2023-06-13 | 10,086 | $19.83 | $200.0K | 25,594 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-05-17 | 2023-05-19 | 2,100 | — | $0 | 2,100 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-05-17 | 2023-05-19 | 4,290 | — | $0 | 4,290 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 7,520 | — | $0 | 7,520 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 4,444 | — | $0 | 9,414 | SEC↗ |
| OGN Organon & Co. | A Award deriv | 2022-06-10 | 2022-06-14 | 5,640 | $35.46 | $200.0K | 14,935 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2022-06-06 | 2022-06-08 | 18,500 | — | $0 | 18,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-05-18 | 2022-05-20 | 9,724 | — | $0 | 9,724 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 3,688 | — | $0 | 3,688 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 2,546 | — | $0 | 4,970 | SEC↗ |
| OGN Organon & Co. | A Award deriv | 2021-06-04 | 2021-06-08 | 9,061 | $36.05 | $326.6K | 9,061 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2021-06-03 | 2021-06-07 | 18,500 | — | $0 | 18,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-05-19 | 2021-05-20 | 8,833 | — | $0 | 8,833 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | A Award deriv | 2021-05-10 | 2021-05-12 | 32,800 | — | $0 | 32,800 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-03-26 | 2021-03-30 | 3,523 | — | $0 | 3,523 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-03-26 | 2021-03-30 | 2,424 | — | $0 | 2,424 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise deriv | 2021-02-10 | 2021-02-26 | 25,000 | — | $0 | 0 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise | 2021-02-10 | 2021-02-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-26 | 10,000 | $10.00 | $100.0K | 35,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-14 | 2020-10-16 | 375 | $87.99 | $33.0K | 97,812 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-08-17 | 2020-08-19 | 500 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-08-17 | 2020-08-19 | 3,669 | — | $0 | 15,312 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-08-17 | 2020-08-19 | 7,188 | — | $0 | 15,812 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-17 | 2020-08-19 | 3,669 | $88.38 | $324.3K | 98,187 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-17 | 2020-08-19 | 461 | $88.24 | $40.7K | 100,747 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-17 | 2020-08-19 | 2,560 | $88.54 | $226.7K | 98,187 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-08-17 | 2020-08-19 | 500 | $70.57 | $35.3K | 98,687 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-17 | 2020-08-19 | 500 | $88.38 | $44.2K | 98,187 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-08-17 | 2020-08-19 | 7,188 | $67.55 | $485.5K | 105,375 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-17 | 2020-08-19 | 7,188 | $88.38 | $635.3K | 98,187 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-08-17 | 2020-08-19 | 3,669 | $48.43 | $177.7K | 101,856 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2020-06-05 | 2020-06-08 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-06-04 | 2020-06-05 | 2,564 | — | $0 | 18,981 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-06-04 | 2020-06-05 | 2,564 | $74.01 | $189.8K | 101,208 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-06-04 | 2020-06-05 | 2,564 | $48.43 | $124.2K | 103,772 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-06-03 | 2020-06-05 | 10,234 | — | $0 | 21,545 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-06-03 | 2020-06-05 | 10,234 | $48.43 | $495.6K | 111,442 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-06-03 | 2020-06-05 | 10,234 | $74.23 | $759.7K | 101,208 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-06-01 | 2020-06-03 | 348 | $69.38 | $24.1K | 101,208 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-05-19 | 2020-05-20 | 3,907 | — | $0 | 500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-05-19 | 2020-05-20 | 3,221 | — | $0 | 31,779 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-05-19 | 2020-05-20 | 3,221 | $48.43 | $156.0K | 104,165 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-05-19 | 2020-05-20 | 3,221 | $73.32 | $236.2K | 100,944 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-05-19 | 2020-05-20 | 3,907 | $73.32 | $286.5K | 101,556 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-05-19 | 2020-05-20 | 3,907 | $70.57 | $275.7K | 104,851 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-05-18 | 2020-05-20 | 19,593 | — | $0 | 4,407 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-05-18 | 2020-05-20 | 19,593 | $70.57 | $1.38M | 122,929 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-05-18 | 2020-05-20 | 19,593 | $73.34 | $1.44M | 103,336 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-05-18 | 2020-05-20 | 2,392 | $73.29 | $175.3K | 100,944 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | A Award deriv | 2020-05-13 | 2020-05-15 | 41,038 | — | $0 | 41,038 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-05-06 | 2020-05-08 | 248 | $66.26 | $16.4K | 103,336 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-04-19 | 2020-04-21 | 248 | $58.57 | $14.5K | 103,584 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-03-01 | 2020-03-03 | 2,325 | $56.08 | $130.4K | 103,832 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 5,634 | — | $0 | 106,157 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-01 | 2020-02-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-10-14 | 2019-10-16 | 1,434 | — | $0 | 100,523 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2019-09-16 | 2019-09-17 | 6,963 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2019-09-16 | 2019-09-17 | 24,880 | — | $0 | 2,998 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2019-09-16 | 2019-09-17 | 24,880 | $6.86 | $170.7K | 99,089 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2019-09-16 | 2019-09-17 | 6,963 | $0.81 | $5.6K | 74,209 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 5,000 | $48.00 | $240.0K | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 5,000 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2019-06-17 | 2019-06-19 | 11,610 | — | $0 | 11,610 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-06-01 | 2019-06-04 | 346 | $54.93 | $19.0K | 67,246 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-05-21 | 2019-05-22 | 381 | $59.50 | $22.7K | 67,592 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-05-06 | 2019-05-07 | 1,434 | — | $0 | 67,973 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-04-19 | 2019-04-23 | 248 | $64.43 | $16.0K | 66,078 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2019-03-18 | 2019-04-17 | 12,000 | — | $0 | 27,878 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-03-18 | 2019-04-17 | 14,800 | $70.00 | $1.04M | 66,326 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2019-03-18 | 2019-04-17 | 12,000 | $6.86 | $82.3K | 81,126 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2019-03-18 | 2019-03-20 | 12,000 | — | $0 | 27,878 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2019-03-18 | 2019-03-20 | 12,000 | $6.86 | $82.3K | 81,157 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-03-18 | 2019-03-20 | 14,800 | $70.00 | $1.04M | 66,357 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-03-05 | 2019-04-17 | 1,012 | $65.52 | $66.3K | 69,125 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-04-17 | 23,000 | — | $0 | 23,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-04-17 | 8,000 | — | $0 | 70,137 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-03-04 | 23,000 | — | $0 | 23,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-03-01 | 2019-03-04 | 981 | $67.55 | $66.3K | 69,156 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-03-04 | 8,000 | — | $0 | 70,137 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2018-11-08 | 2018-11-13 | 26,033 | — | $0 | 26,033 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2018-10-31 | 2018-10-31 | 12,000 | — | $0 | 6,963 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2018-10-31 | 2018-10-31 | 12,000 | $0.82 | $9.8K | 62,128 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-10-26 | 2018-10-29 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-10-26 | 2018-10-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-10-25 | 2018-10-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-10-25 | 2018-10-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2018-09-25 | 2018-09-27 | 3,350 | — | $0 | 18,963 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-09-25 | 2018-09-27 | 6,700 | $90.07 | $603.5K | 50,128 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2018-09-25 | 2018-09-27 | 3,350 | $0.82 | $2.7K | 56,828 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-06-21 | 2018-06-22 | 10,000 | $2.50 | $25.0K | 10,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-06-20 | 2018-06-22 | 37,500 | $5.65 | $211.9K | 37,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2018-06-07 | 2018-06-07 | 3,350 | — | $0 | 22,313 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2018-06-07 | 2018-06-07 | 3,350 | $0.82 | $2.7K | 60,178 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-06-07 | 2018-06-07 | 6,700 | $80.07 | $536.5K | 53,478 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-06-01 | 2018-06-04 | 346 | $73.73 | $25.5K | 56,828 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2018-05-30 | 2018-05-30 | 6,500 | — | $0 | 25,663 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2018-05-30 | 2018-05-30 | 6,500 | $0.82 | $5.3K | 70,174 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-05-30 | 2018-05-30 | 13,000 | $70.17 | $912.2K | 57,174 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-05-21 | 2018-05-22 | 381 | $64.79 | $24.7K | 63,674 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-04-19 | 2018-04-19 | 1,431 | — | $0 | 63,544 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-03-02 | 2018-06-22 | 18,533 | $5.65 | $104.7K | 18,533 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-03-02 | 2018-03-06 | 18,533 | $5.65 | $104.7K | 18,533 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-03-01 | 2018-03-05 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-03-01 | 2018-03-05 | 7,000 | — | $0 | 62,510 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-03-01 | 2018-03-05 | 397 | $48.43 | $19.2K | 62,113 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-10-26 | 2017-10-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-10-26 | 2017-10-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2017-06-29 | 2017-07-03 | 50,000 | $3.91 | $195.5K | 50,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2017-06-01 | 2017-06-01 | 376 | $56.61 | $21.3K | 55,470 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2017-05-21 | 2017-05-22 | 414 | $57.47 | $23.8K | 55,846 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2017-03-02 | 2017-03-03 | 12,000 | — | $0 | 32,163 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2017-03-02 | 2017-03-03 | 12,000 | $90.10 | $1.08M | 55,887 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2017-03-02 | 2017-03-03 | 12,000 | $0.82 | $9.8K | 67,887 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2017-03-01 | 2017-03-01 | 28,000 | — | $0 | 28,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2017-03-01 | 2017-03-01 | 4,000 | — | $0 | 55,887 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2017-02-27 | 2017-02-28 | 12,000 | — | $0 | 44,163 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2017-02-27 | 2017-02-28 | 12,000 | $80.14 | $961.7K | 51,887 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2017-02-27 | 2017-02-28 | 12,000 | $0.82 | $9.8K | 63,887 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2016-12-23 | 2016-12-23 | 6,500 | — | $0 | 56,163 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2016-12-23 | 2016-12-23 | 6,500 | $0.81 | $5.3K | 51,887 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2016-11-09 | 2016-11-10 | 24,000 | — | $0 | 62,663 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-09 | 2016-11-10 | 3,895 | $71.68 | $279.2K | 51,892 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-09 | 2016-11-10 | 700 | $74.34 | $52.0K | 45,387 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-09 | 2016-11-10 | 2,600 | $73.65 | $191.5K | 46,087 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-09 | 2016-11-10 | 3,205 | $72.81 | $233.4K | 48,687 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2016-11-09 | 2016-11-10 | 24,000 | $0.82 | $19.7K | 69,387 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-09 | 2016-11-10 | 13,600 | $70.06 | $952.8K | 55,787 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2016-10-19 | 2016-10-21 | 12,000 | — | $0 | 86,663 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-10-19 | 2016-10-21 | 6,932 | $61.71 | $427.8K | 45,387 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2016-10-19 | 2016-10-21 | 12,000 | $0.82 | $9.8K | 57,387 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-10-19 | 2016-10-21 | 5,068 | $60.98 | $309.0K | 52,319 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2016-09-16 | 2016-09-20 | 13,711 | — | $0 | 13,711 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2016-06-15 | 2016-06-17 | 35,000 | $3.91 | $136.8K | 35,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-01 | 2016-06-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-01 | 2016-06-03 | 4,000 | — | $0 | 45,387 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-05-21 | 2016-05-24 | 414 | $64.01 | $26.5K | 41,387 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2015-12-10 | 2015-12-14 | 12,000 | — | $0 | 98,663 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-10 | 2015-12-14 | 6,723 | $102.16 | $686.8K | 47,078 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-10 | 2015-12-14 | 5,277 | $101.03 | $533.1K | 41,801 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2015-12-10 | 2015-12-14 | 12,000 | $0.82 | $9.8K | 53,801 | SEC↗ |
| AGEN AGENUS INC | A Award | 2015-09-28 | 2015-09-29 | 22,000 | $4.59 | $101.0K | 104,270 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-20 | 2015-07-22 | 1,412 | $131.56 | $185.8K | 42,289 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-20 | 2015-07-22 | 488 | $130.99 | $63.9K | 41,801 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-20 | 2015-07-22 | 1,954 | $132.47 | $258.8K | 43,701 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-20 | 2015-07-22 | 488 | $130.99 | $63.9K | 41,801 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-20 | 2015-07-22 | 1,954 | $132.47 | $258.8K | 43,701 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-20 | 2015-07-22 | 1,412 | $131.56 | $185.8K | 42,289 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2015-06-25 | 2015-06-29 | 18,750 | $8.43 | $158.1K | 18,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-06-18 | 2015-06-19 | 1,349 | $96.35 | $130.0K | 45,655 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-06-18 | 2015-06-19 | 2,651 | $95.95 | $254.4K | 47,004 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2015-05-21 | 2015-05-27 | 26,300 | — | $0 | 26,300 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2015-05-21 | 2015-05-27 | 4,400 | — | $0 | 49,655 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-05-18 | 2015-05-20 | 4,000 | $79.43 | $317.7K | 45,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2015-05-01 | 2015-05-05 | 1,000 | — | $0 | 110,663 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2015-05-01 | 2015-05-05 | 1,000 | $0.82 | $820 | 49,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-04-20 | 2015-04-22 | 1,000 | $61.14 | $61.1K | 51,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-04-20 | 2015-04-22 | 3,000 | $62.59 | $187.8K | 48,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-03-18 | 2015-03-20 | 4,000 | $61.45 | $245.8K | 52,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-02-18 | 2015-02-20 | 3,704 | $53.93 | $199.8K | 56,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-02-18 | 2015-02-20 | 296 | $54.72 | $16.2K | 59,959 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-01-20 | 2015-01-22 | 4,000 | $51.24 | $205.0K | 60,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-12-18 | 2014-12-22 | 4,000 | $44.82 | $179.3K | 64,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-11-20 | 2014-11-21 | 4,000 | $44.07 | $176.3K | 68,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-10-20 | 2014-10-22 | 4,000 | $46.02 | $184.1K | 72,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-09-18 | 2014-09-19 | 4,000 | $56.00 | $224.0K | 76,255 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-08-18 | 2014-08-19 | 4,000 | $53.97 | $215.9K | 80,255 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2014-04-24 | 2014-04-29 | 15,000 | $2.71 | $40.6K | 15,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | P Buy | 2014-01-30 | 2014-02-03 | 4,500 | $21.00 | $94.5K | 84,255 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2013-01-30 | 2013-02-01 | 288 | $4.36 | $1.3K | 81,311 | SEC↗ |
| AGEN AGENUS INC | A Award | 2013-01-28 | 2013-01-29 | 625 | $4.35 | $2.7K | 81,599 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2012-10-31 | 2012-11-01 | 288 | $4.40 | $1.3K | 80,974 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-10-26 | 2012-10-29 | 625 | $4.42 | $2.8K | 81,262 | SEC↗ |
| AGEN AGENUS INC | E Expire deriv | 2012-09-12 | 2012-09-14 | 827 | — | $0 | 139,249 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-09-12 | 2012-09-14 | 4,035 | — | $0 | 80,637 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2012-08-29 | 2012-08-31 | 288 | $4.64 | $1.3K | 76,602 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-07-26 | 2012-07-30 | 625 | $4.61 | $2.9K | 76,890 | SEC↗ |
| AGEN AGENUS INC | D To issuer | 2012-06-21 | 2012-06-21 | 4,107 | $5.05 | $20.7K | 76,265 | SEC↗ |
| AGEN AGENUS INC | D To issuer | 2012-06-20 | 2012-06-21 | 2,218 | $4.92 | $10.9K | 80,372 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-06-19 | 2012-06-21 | 12,713 | $5.26 | $66.9K | 82,590 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2012-06-14 | 2012-06-18 | 7,500 | $5.34 | $40.0K | 144,736 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-04-26 | 2012-04-30 | 625 | $6.43 | $4.0K | 69,877 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-03-15 | 2012-03-16 | 4,862 | $5.31 | $25.8K | 69,252 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-01-26 | 2012-01-31 | 625 | $2.76 | $1.7K | 64,390 | SEC↗ |
| AGEN AGENUS INC | A Award | 2012-01-03 | 2012-01-05 | 22,121 | $2.17 | $48.0K | 63,765 | SEC↗ |